RECRUITING

Exercise and Movement to Enhance Resiliency in Cancer Patients

Description

This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.

Conditions

Gynecologic Cancer
Talk to us

Related Conditions:

Gynecologic Cancer

Study Overview

On this page

Study Details

Study overview

This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.

EMPOWER: Exercise and Movement to Promote Our Patients With (Gynecologic) Cancer to Enhance Resiliency

Exercise and Movement to Enhance Resiliency in Cancer Patients

Condition
Gynecologic Cancer
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18 years or older.
  • 2. Newly diagnosed with a gynecological cancer (including ovarian tubal or peritoneal, uterine, cervical, vaginal, vulvar, and/or gestational trophoblastic neoplasia) and currently undergoing treatment chemotherapy, surgery, etc.).
  • 3. Able to understand study procedures and to comply with them for the entire length of the study.
  • 4. Ability to understand a written informed consent document, and the willingness to sign it.
  • 5. Eastern Cooperative Oncology Group (ECOG) status \< 4.
  • 6. Willingness to participate and wear an activity tracker (e.g., Move wearable or equivalent).
  • 7. Planning to start systemic treatment or currently receiving Cycle 1 of systemic treatment.
  • 1. Medically ineligible or contraindications to exercise as determined by their oncologist; or contradiction to any other study-related procedure or assessment.
  • 2. Cognitive or visual impairments that would limit participant's ability to utilize and interact with the DHT platform.
  • 3. Existing performance of excessive physical activity (\>210 minutes per week of moderate to vigorous intensity exercise at baseline).
  • 4. Existing enrollment in an exercise program or physical therapy program.
  • 5. Inability to speak and read English.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Stephanie Cham, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2031-08-31